𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: A potential treatment for infected bone defects

✍ Scribed by Akinobu Suzuki; Hidetomi Terai; Hiromitsu Toyoda; Takashi Namikawa; Yoshiko Yokota; Takanori Tsunoda; Kunio Takaoka


Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
206 KB
Volume
24
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To produce an osteogenic and bacteriocidal biomaterial for the treatment of infected nonunions or bone defects, a synthetic degradable block copolymer of poly‐D,L‐lactic acid segments with randomly inserted p‐dioxanone and polyethylene glycol (PLA‐DX‐PEG) segments was mixed with recombinant human BMP‐2 (rhBMP‐2) and antibiotics at high concentration. We then examined the in vitro elution profile of an antibiotic (teicoplanin) from the polymer, the effects of antibiotics on the bone‐inducing capacity of rhBMP‐2 or on ectopic new bone formation induced by the rhBMP, and the ability of the polymer to repair bone in a rat cranial defect model. Approximately 40% of teicoplanin was released within the first 24 h, with the remaining amount released steadily over 21 days with no loss of antibacterial activity. The polymer had disappeared by degradation in the phosphate buffered saline (pH 7.4) at the end of the incubation period. The in vivo performance of pellets with antibiotics and rhBMP‐2 revealed no significant change in bone yield within the ossicles after 3 weeks. Also, antibiotics had no inhibitory effect on the ability of rhBMP2 to repair cranial defects. Indeed, when the defect was filled by a polymer disc loaded with rhBMP‐2 with or without teicoplanin, the defect was repaired by new bone, and normal anatomy was restored within 6 weeks. In conclusion, the PLA/DX/PEG polymer appears to work as effectively for antibiotics as it does for rhBMP‐2. Additionally, the biological activity of rhBMP‐2 was retained irrespective of the presence of antibiotics. © 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 24:327–332, 2006


📜 SIMILAR VOLUMES


Recombinant human bone morphogenetic pro
✍ Ayako Takeuchi; Hidetsugu Tsujigiwa; Jun Murakami; Akihiro Kawasaki; Yasushi Tak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB

## Abstract Ossicular reconstruction is the rebuilding of the damaged middle ear. There are many different prosthesis and techniques used to reconstruct the middle ear ossicles. However, precision in the surgical procedures and prostheses used for ossiculoplasty are still imperfect. The objective o

Experimental studies on bone induction u
✍ Bessho, K. ;Carnes, D. L. ;Cavin, R. ;Ong, J. L. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

## Abstract An appropriate carrier acting as a slow delivery vehicle for the BMPs is required for maximal clinical effectiveness of these bone‐inductive proteins. The purpose of this study was to evaluate a low‐molecular‐weight PLGA copolymer as a synthetic, biodegradable carrier for rhBMP‐2 implan